The global sustainable drug manufacturing market is projected to grow from USD 105.8 billion in 2026 to USD 248.2 billion by 2036, expanding at a CAGR of 8.9% during the forecast period. The market is gaining momentum as pharmaceutical manufacturers prioritize lower solvent and energy intensity while maintaining validated quality, regulatory compliance, and process...